Istanbul - Delayed Quote TRY
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (GENIL.IS)
121.30
+1.30
+(1.08%)
At close: April 25 at 6:09:51 PM GMT+3
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TRY.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Abidin Gulmus | Chairman of the Board & GM | -- | -- | -- |
Semra Gulmus | Founder | -- | -- | -- |
Dr. Deniz Karagulle | Vice President of Sales & Marketing | -- | -- | 1970 |
Yagmur Selin Gulmus Kolay | Assistant General Manager of Strategy & Corporate Development | -- | -- | 1988 |
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
Mustafa Kemal District 2119
Street No:3
Çankaya, 06520
Turkey
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 619
Description
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Corporate Governance
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
October 8, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
AEQ.F Aequus Pharmaceuticals Inc.
0.0005
0.00%
5SS0.F Simply Better Brands Corp.
0.5340
+3.49%
GABA.ST Gabather AB (publ)
0.0396
-2.94%
VCBD Vitalibis, Inc.
0.0018
+28.57%
KLAR.ST Klaria Pharma Holding AB (publ.)
1.1500
-3.77%
STX.L Shield Therapeutics plc
2.3500
+3.98%
CRNO-B.ST Cereno Scientific AB (publ)
8.00
+0.38%
CPIX Cumberland Pharmaceuticals Inc.
4.9700
+2.58%
BCRX BioCryst Pharmaceuticals, Inc.
8.39
+2.07%